Loading...
Loading...
Insulet Corporation
PODD, the leader in tubeless insulin pump technology, today
announced that the Company has received 510(k) clearance from the
U.S. Food and Drug Administration (FDA) for the next-generation
OmniPod(R) Insulin Management System. The new OmniPod insulin pump is
more than one-third smaller and one-quarter lighter than the original
model, while maintaining the same 200-unit insulin reservoir capacity
and easy-to-use features. In addition to the smaller, lighter Pod,
the new OmniPod System includes an updated Personal Diabetes Manager
(PDM) that also features a series of enhancements.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in